Terms: = Bone cancer AND HEY1, CHF-2, 23462, ENSG00000164683, HESR1, CHF2, HESR-1, MGC1274, HRT-1, OAF1, HERP2 AND Treatment
12 results:
1. Knocking down SOX2 overcomes the resistance of prostate cancer to castration via notch signaling.
Du Z; Chen X; Zhu P; Lv Q; Yong J; Gu J
Mol Biol Rep; 2023 Nov; 50(11):9007-9017. PubMed ID: 37716921
[TBL] [Abstract] [Full Text] [Related]
2. Construction of a transcription factor-miRNA-mRNA interactive network elucidates underlying pathogenesis for osteosarcoma and validation by qRT-PCR.
Tang F; Jiang X; Liao S; Liu Y; He M
Medicine (Baltimore); 2022 Oct; 101(41):e31049. PubMed ID: 36254052
[TBL] [Abstract] [Full Text] [Related]
3. Patient-derived xenografts and in vitro model show rationale for imatinib mesylate repurposing in hey1-NCoA2-driven mesenchymal chondrosarcoma.
Safaric Tepes P; Segovia D; Jevtic S; Ramirez D; Lyons SK; Sordella R
Lab Invest; 2022 Sep; 102(9):1038-1049. PubMed ID: 34837064
[TBL] [Abstract] [Full Text] [Related]
4. Causal Bayesian gene networks associated with bone, brain and lung metastasis of breast cancer.
Park SB; Hwang KT; Chung CK; Roy D; Yoo C
Clin Exp Metastasis; 2020 Dec; 37(6):657-674. PubMed ID: 33083937
[TBL] [Abstract] [Full Text] [Related]
5. Doxorubicin Inhibits Proliferation of Osteosarcoma Cells Through Upregulation of the Notch Signaling Pathway.
Ji P; Yu L; Guo WC; Mei HJ; Wang XJ; Chen H; Fang S; Yang J
Oncol Res; 2014; 22(4):185-191. PubMed ID: 26351207
[TBL] [Abstract] [Full Text] [Related]
6. Intraparenchymal mesenchymal chondrosarcoma of the frontal lobe--a case report and molecular detection of specific gene fusions from archival FFPE sample.
Sajjad EA; Sikora K; Paciejewski T; Garbicz F; Paskal W; Szacht M; Grajkowska W; Włodarski PK
Clin Neuropathol; 2015; 34(5):288-93. PubMed ID: 25907264
[TBL] [Abstract] [Full Text] [Related]
7. Serum induces transcription of hey1 and Hey2 genes by Alk1 but not Notch signaling in endothelial cells.
Wöltje K; Jabs M; Fischer A
PLoS One; 2015; 10(3):e0120547. PubMed ID: 25799559
[TBL] [Abstract] [Full Text] [Related]
8. Suppression of deacetylase SIRT1 mediates tumor-suppressive NOTCH response and offers a novel treatment option in metastatic Ewing sarcoma.
Ban J; Aryee DN; Fourtouna A; van der Ent W; Kauer M; Niedan S; Machado I; Rodriguez-Galindo C; Tirado OM; Schwentner R; Picci P; Flanagan AM; Berg V; Strauss SJ; Scotlandi K; Lawlor ER; Snaar-Jagalska E; Llombart-Bosch A; Kovar H
Cancer Res; 2014 Nov; 74(22):6578-88. PubMed ID: 25281719
[TBL] [Abstract] [Full Text] [Related]
9. HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors.
Dailey DD; Anfinsen KP; Pfaff LE; Ehrhart EJ; Charles JB; Bønsdorff TB; Thamm DH; Powers BE; Jonasdottir TJ; Duval DL
BMC Vet Res; 2013 Jul; 9():130. PubMed ID: 23816051
[TBL] [Abstract] [Full Text] [Related]
10. Inhibition of Notch pathway prevents osteosarcoma growth by cell cycle regulation.
Tanaka M; Setoguchi T; Hirotsu M; Gao H; Sasaki H; Matsunoshita Y; Komiya S
Br J Cancer; 2009 Jun; 100(12):1957-65. PubMed ID: 19455146
[TBL] [Abstract] [Full Text] [Related]
11. Lessons learned from the WHI: HRT requires a cautious and individualized approach.
Aubuchon M; Santoro N
Geriatrics; 2004 Nov; 59(11):22-6. PubMed ID: 15615157
[TBL] [Abstract] [Full Text] [Related]
12. Hormone replacement therapy after treatment of breast cancer: effects on postmenopausal symptoms, bone mineral density and recurrence rates.
Beckmann MW; Jap D; Djahansouzi S; Nestle-Krämling C; Kuschel B; Dall P; Brumm C; Bender HG
Oncology; 2001; 60(3):199-206. PubMed ID: 11340370
[TBL] [Abstract] [Full Text] [Related]
